Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists

被引:20
作者
Doherty, GA [1 ]
Yang, GX
Borges, E
Chang, LL
MacCoss, M
Tong, S
Kidambi, U
Egger, LA
McCauley, E
Van Riper, G
Mumford, RA
Schmidt, JA
Hagmann, WK
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol & Rheumatol Res, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(02)00211-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of substituted tetra hydrofuroyl-1-phenylalanine derivatives was prepared and evaluated as VLA-4 antagonists. Substitution of the a carbon of the tetrahydrofuran with aryl groups increased the specificity for VLA-4 versus alpha(4)beta(7) while amide substitution increased the potency of the series without increasing the specificity. Substitution of the P carbon of the tetrahydrofuran with keto or amino groups slightly improved the specificity for VLA-4 versus alpha(4)beta(7) but with a significant loss in binding affinity for VLA-4. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1501 / 1505
页数:5
相关论文
共 50 条
[21]   VLA-4 antagonists [J].
Tilley, JW ;
Sidduri, A .
DRUGS OF THE FUTURE, 2001, 26 (10) :985-998
[22]   Antagonists of VLA-4 [J].
Holland, GW ;
Biediger, RJ ;
Vanderslice, P .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 :65-74
[23]   VLA-4 antagonists [J].
Tilley, JW .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (07) :991-1008
[24]   Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists [J].
Tilley, JW ;
Kaplan, G ;
Rowan, K ;
Schwinge, V ;
Wolitzky, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) :1-4
[25]   Squaric acid derivatives as VLA-4 integrin antagonists [J].
Porter, JR ;
Archibald, SC ;
Childs, K ;
Critchley, D ;
Head, JC ;
Linsley, JM ;
Parton, TAH ;
Robinson, MK ;
Shock, A ;
Taylor, RJ ;
Warrellow, GJ ;
Alexander, RP ;
Langham, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) :1051-1054
[26]   Tertiary amide ureido derivatives VLA-4 antagonists [J].
不详 .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (03) :361-364
[27]   N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists [J].
Li, B ;
de Laszlo, SE ;
Kamenecka, TM ;
Kopka, IE ;
Durette, PL ;
Lanza, T ;
MacCoss, M ;
Tong, S ;
Mumford, RA ;
McCauley, ED ;
Van Riper, G ;
Schmidt, JA ;
Hagmann, WK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) :2141-2144
[28]   Novel urea analogs that are potent VLA-4 antagonists. [J].
Biediger, RJ ;
Scott, IL ;
Raju, BG ;
Ren, KJ ;
Market, RV ;
Keller, KM ;
Lin, SQ ;
Kassir, JM ;
Grabbe, VO ;
Kogan, TP ;
Krudy, GA ;
Ghen, Q ;
Holland, GW ;
Maxwell, DC ;
You, TJ ;
Vanderslice, P ;
West, H ;
Decker, ER ;
Tilton, R ;
Munsch, CL ;
Dixon, RAF .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 :U53-U53
[29]   Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists [J].
Chiba, Jun ;
Iimura, Shin ;
Yoneda, Yoshiyuki ;
Watanabe, Toshiyuki ;
Muro, Fumito ;
Tsubokawa, Masao ;
Iigou, Yutaka ;
Satoh, Atsushi ;
Takayama, Gensuke ;
Yokoyama, Mika ;
Takashi, Tohru ;
Nakayama, Atsushi ;
Machinaga, Nobuo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (04) :1679-1693
[30]   The discovery of VLA-4 antagonists [J].
Tilley, JW ;
Chen, L ;
Sidduri, A ;
Fotouhi, N .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (14) :1509-1523